Ticker Symbol: ORGO
Organogenesis Holdings Inc - Class A
$10.99 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001661181
Company Profile
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 85 Dan Rd
Website: www.organogenesis.com
CEO: N/A
Tags:
- Finance
- Financial Conglomerates
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.94
Change:
-$0.03
(
-1.01%)
Days Range: $2.90 - $3.02
Beta: 1.11
52wk. High: $4.50
52wk. Low: $1.80
Ytd. Change 9.40%
50 Day Moving Average: $2.63
200 Day Moving Average: $3.03
Shares Outstanding: 131311852
Valuation
Market Cap: 38.6B
PE Ratio: 42.92
EPS (TTM): 0.0685
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A